Hindustan Foods Ltd
Hindustan Foods Limited is an India-based company, which is engaged in contract manufacturing of various FMCG products including food, home care, personal care, beverages etc. They also do manufacturing of leather shoes and accessories
- Market Cap ₹ 6,237 Cr.
- Current Price ₹ 544
- High / Low ₹ 686 / 461
- Stock P/E 65.6
- Book Value ₹ 61.5
- Dividend Yield 0.00 %
- ROCE 15.4 %
- ROE 18.2 %
- Face Value ₹ 2.00
Pros
- Company has delivered good profit growth of 50.9% CAGR over last 5 years
Cons
- Stock is trading at 8.84 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: FMCG Industry: Diversified - Large
Part of BSE SmallCap BSE Allcap Nifty Microcap 250 Nifty Total Market BSE Fast Moving Consumer Goods
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|
492 | 772 | 1,407 | 2,040 | 2,598 | 2,755 | 3,211 | |
459 | 717 | 1,319 | 1,927 | 2,425 | 2,533 | 2,952 | |
Operating Profit | 33 | 55 | 88 | 113 | 173 | 222 | 260 |
OPM % | 7% | 7% | 6% | 6% | 7% | 8% | 8% |
1 | 1 | 3 | 4 | 5 | 7 | 10 | |
Interest | 8 | 11 | 19 | 20 | 36 | 57 | 74 |
Depreciation | 7 | 11 | 19 | 25 | 37 | 55 | 72 |
Profit before tax | 18 | 34 | 52 | 71 | 104 | 117 | 125 |
Tax % | 35% | 35% | 29% | 38% | 32% | 21% | |
12 | 22 | 37 | 45 | 71 | 93 | 95 | |
EPS in Rs | 1.76 | 2.07 | 3.52 | 3.96 | 6.31 | 8.12 | 8.33 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 41% |
3 Years: | 25% |
TTM: | 22% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 51% |
3 Years: | 36% |
TTM: | 12% |
Stock Price CAGR | |
---|---|
10 Years: | 53% |
5 Years: | 32% |
3 Years: | 14% |
1 Year: | -2% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 18% |
3 Years: | 19% |
Last Year: | 18% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|
Equity Capital | 13 | 21 | 21 | 23 | 23 | 23 | 23 |
Reserves | 51 | 165 | 232 | 281 | 352 | 622 | 682 |
100 | 165 | 218 | 350 | 516 | 731 | 811 | |
102 | 188 | 266 | 331 | 445 | 549 | 717 | |
Total Liabilities | 266 | 539 | 737 | 984 | 1,335 | 1,924 | 2,232 |
133 | 250 | 308 | 427 | 554 | 908 | 993 | |
CWIP | 0 | 26 | 53 | 87 | 125 | 9 | 4 |
Investments | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
133 | 261 | 375 | 470 | 656 | 1,007 | 1,234 | |
Total Assets | 266 | 539 | 737 | 984 | 1,335 | 1,924 | 2,232 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|
-5 | 17 | 72 | 36 | 99 | 87 | |
-40 | -145 | -90 | -139 | -220 | -381 | |
43 | 153 | 34 | 91 | 128 | 298 | |
Net Cash Flow | -2 | 24 | 16 | -12 | 7 | 3 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|
Debtor Days | 32 | 18 | 13 | 13 | 15 | 23 |
Inventory Days | 54 | 74 | 58 | 56 | 68 | 98 |
Days Payable | 84 | 94 | 74 | 64 | 69 | 85 |
Cash Conversion Cycle | 2 | -2 | -3 | 5 | 14 | 37 |
Working Capital Days | 6 | 11 | 13 | 17 | 22 | 43 |
ROCE % | 17% | 17% | 16% | 18% | 15% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
21 Nov - Transcript of Analyst/Investors conference call for Q2 FY '25.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
13 Nov - Submission of audio recording of investor conference call.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 13 Nov
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
12 Nov - Exchanges that, the officials of the Company will be attending the Meeting with Investors/Analysts (Participants), the details of which are mentioned in attached PDF file.
-
Compliances- Statement Of Deviation Or Variation In The Use Of Proceeds Raised Through Preferential Issue
12 Nov - Statement confirming no deviation in fund usage.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Concalls
-
Nov 2024Transcript PPT REC
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
May 2023TranscriptNotesPPT
-
Feb 2023Transcript PPT
-
Nov 2022TranscriptNotesPPT
-
Nov 2022Transcript PPT
-
Nov 2022TranscriptNotesPPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
Feb 2022TranscriptNotesPPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
May 2021Transcript PPT
-
Feb 2021Transcript PPT
-
Nov 2020Transcript PPT
-
Aug 2020TranscriptNotesPPT
-
Jul 2020TranscriptNotesPPT
-
Jul 2020TranscriptNotesPPT
-
Feb 2020TranscriptNotesPPT
-
Nov 2019TranscriptNotesPPT
-
Aug 2019TranscriptNotesPPT
-
Aug 2019TranscriptNotesPPT
-
Mar 2018TranscriptNotesPPT
Acquired by Van group[1] Hindustan Food Limited (HFL) started a joint venture between Glaxo Smith Kline and the Dempo group to manufacture a nutritional food product under the brand name of ‘Farex’ but the venture made losses for many years as it was dependent on a single brand. In 2013, Dempo Foods Pvt. Ltd., the Holding Company of Hindustan Foods Ltd was acquired by Vanity Case India Pvt. Ltd., and the latter bought 74.45% of the paid-up share capital.